Group sequential design using restricted mean survival time as the primary endpoint in clinical trials.

导出 LinkOut

翻译打印收藏纠错

作者： Zhaojin,Li ^[1] ; Xiang,Geng ^[1] ; Yawen,Hou ^[2] ; Zheng,Chen ^[3]

作者单位： Department of Biostatistics, School of Public Health (Guangdong Provincial Key Laboratory of Tropical Disease Research), Southern Medical University, Guangzhou, China. ^[1] Department of Statistics and Data Science, School of Economics, Jinan University, Guangzhou, China. ^[2] Department of Biostatistics, School of Public Health (Guangdong Provincial Key Laboratory of Tropical Disease Research), Southern Medical University, Guangzhou, China.;State Key Laboratory of Organ Failure Research, Guangzhou, China. ^[3]

关键词 Restricted mean survival time group sequential design non-proportional hazards survival analysis

DOI 10.1177/09622802241304111

PMID 39828918

发布时间 2025-01-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Statistical methods in medical research

9622802241304111页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Group sequential design using restricted mean survival time as the primary endpoint in clinical trials.

Statistical methods in medical research

相似文献

Statistical methods in medical research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Group sequential design using restricted mean survival time as the primary endpoint in clinical trials.

Statistical methods in medical research

相似文献

Statistical methods in medical research

相关期刊

检索历史清除